📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
TIINDIA Q3 PAT Rises 17.6% to ₹189 Cr; Declares ₹2 Interim Dividend
Tube Investments of India (TIINDIA) reported a steady Q3 FY26 with standalone revenue growing 12.7% YoY to ₹2,152.22 crore. Standalone Profit After Tax (PAT) saw a healthy increase of 17.6% YoY, reaching ₹188.99 crore. The company declared an interim dividend of ₹2 per share (200% of face value) with a record date of February 10, 2026. Additionally, the board approved the reappointment of two independent directors and the reclassification of Algavista Greentech from the promoter to the public category.
Key Highlights
Standalone Revenue from Operations increased to ₹2,152.22 Cr in Q3 FY26 from ₹1,910.16 Cr in Q3 FY25.
Standalone Profit After Tax (PAT) grew 17.6% YoY to ₹188.99 Cr for the quarter ended December 2025.
Interim Dividend of ₹2 per equity share declared; Record Date fixed as February 10, 2026.
Nine-month Standalone PAT for FY26 reached ₹543.83 Cr compared to ₹483.01 Cr in the previous year.
Board approved reclassification of Algavista Greentech Private Limited from 'Promoter' to 'Public' category.
💼 Action for Investors
Investors should note the steady double-digit growth in both revenue and profitability. The stock remains attractive for dividend seekers with the upcoming record date on February 10.
TIINDIA Q3 PAT Rises 17.6% to ₹189 Cr; Declares ₹2 Interim Dividend
Tube Investments of India (TIINDIA) reported a steady performance for Q3 FY26, with standalone revenue growing to ₹2,152.22 crore from ₹1,910.16 crore in the previous year. Net profit for the quarter increased by 17.6% year-on-year to ₹188.99 crore. The board declared an interim dividend of ₹2 per share, representing a 200% payout on the face value. Additionally, the company approved the reclassification of Algavista Greentech Private Limited from the promoter group to the public category.
Key Highlights
Standalone Revenue from operations grew 12.7% YoY to ₹2,152.22 crore in Q3 FY26
Standalone Profit After Tax (PAT) increased to ₹188.99 crore from ₹160.74 crore in Q3 FY25
Declared an interim dividend of ₹2 per equity share with a record date of February 10, 2026
Reappointed Independent Directors Anand Kumar and V S Radhakrishnan for second 5-year terms
Approved reclassification of Algavista Greentech Private Limited to Public Shareholder category
💼 Action for Investors
Investors should note the consistent double-digit growth in both revenue and profitability. The dividend declaration and leadership continuity through director reappointments provide further stability for long-term holders.
TIINDIA Q3 PAT Rises 17.6% to ₹189 Cr; Declares ₹2 Interim Dividend & Reappoints Directors
Tube Investments of India (TIINDIA) reported a solid performance for Q3 FY26, with standalone revenue growing 12.7% YoY to ₹2,152.22 Cr. Net profit for the quarter increased by 17.6% YoY to ₹188.99 Cr, reflecting strong operational execution. The board has rewarded shareholders with an interim dividend of ₹2 per share, while also ensuring leadership stability through the reappointment of two key independent directors for second five-year terms. Additionally, the company is processing the reclassification of Algavista Greentech from the promoter group to public shareholders.
Key Highlights
Standalone Revenue from Operations increased 12.7% YoY to ₹2,152.22 Cr in Q3 FY26.
Net Profit (PAT) rose 17.6% YoY to ₹188.99 Cr compared to ₹160.74 Cr in the same quarter last year.
Declared an interim dividend of ₹2 per equity share (200% of face value) with a record date of February 10, 2026.
Reappointed Independent Directors Anand Kumar and V S Radhakrishnan for second 5-year terms starting 2026.
Approved the reclassification of Algavista Greentech Private Limited from 'Promoter' to 'Public' category.
💼 Action for Investors
The steady growth in bottom-line and consistent dividend payouts reinforce TIINDIA's position as a stable compounder. Investors should maintain their positions as the company demonstrates both financial growth and governance continuity.
TIINDIA Q3 PAT Rises 17.6% to ₹189 Cr; Declares ₹2 Interim Dividend
Tube Investments of India (TIINDIA) reported a strong performance for Q3 FY26, with revenue from operations growing 12.7% YoY to ₹2,152.22 crore. Net profit for the quarter increased by 17.6% YoY to ₹188.99 crore, up from ₹160.74 crore in the same period last year. The board has declared an interim dividend of ₹2 per share, representing a 200% payout on the face value of ₹1. Additionally, the company has fixed February 10, 2026, as the record date for the dividend payment.
Key Highlights
Revenue from operations grew to ₹2,152.22 crore in Q3 FY26 compared to ₹1,910.16 crore in Q3 FY25.
Profit After Tax (PAT) for the quarter stood at ₹188.99 crore, a 17.6% increase over the previous year.
Interim dividend of ₹2 per equity share declared with a record date of February 10, 2026.
Nine-month PAT for the period ending December 2025 reached ₹543.83 crore versus ₹483.01 crore YoY.
Board approved the reappointment of two Independent Directors for a second five-year term.
💼 Action for Investors
Investors should track the stock for the upcoming dividend record date of February 10. The consistent growth in both revenue and profitability reinforces the company's strong market position.
TIINDIA Declares Rs 2 Interim Dividend; Q3 Standalone Net Profit Grows 17.6% YoY to Rs 189 Cr
Tube Investments of India (TIINDIA) has declared an interim dividend of Rs 2 per equity share for FY 2025-26, setting February 10, 2026, as the record date. The company reported a healthy standalone performance for Q3 FY26, with revenue rising 12.7% YoY to Rs 2,152.22 crore. Standalone net profit for the quarter increased to Rs 188.99 crore from Rs 160.74 crore in the same period last year. Additionally, the board approved the reappointment of two independent directors and the reclassification of Algavista Greentech from the promoter to the public category.
Key Highlights
Interim dividend of Rs 2 per share (200% of face value) declared with record date of Feb 10, 2026
Standalone Revenue from Operations grew to Rs 2,152.22 Cr in Q3 FY26 vs Rs 1,910.16 Cr YoY
Standalone Profit After Tax (PAT) rose 17.6% YoY to Rs 188.99 Cr
Reappointment of Independent Directors Anand Kumar and V S Radhakrishnan for second 5-year terms
Board approved promoter reclassification request from Algavista Greentech Private Limited
💼 Action for Investors
Investors should maintain their positions to benefit from the Rs 2 dividend, ensuring they hold shares before the February 10 record date. The steady growth in standalone earnings reflects strong operational execution.
TIINDIA Q3 PAT Rises 17.6% to ₹189 Cr; Declares ₹2 Interim Dividend
Tube Investments of India (TIINDIA) reported a steady performance for Q3 FY26, with standalone revenue rising to ₹2,152.22 crore compared to ₹1,910.16 crore in the same period last year. Net profit for the quarter grew by 17.6% year-on-year to ₹188.99 crore. The Board has declared an interim dividend of ₹2 per share, representing a 200% payout on the face value. Additionally, the company approved the reappointment of two independent directors and a promoter reclassification request.
Key Highlights
Standalone Revenue from Operations grew 12.7% YoY to ₹2,152.22 crore in Q3 FY26.
Net Profit (PAT) increased to ₹188.99 crore from ₹160.74 crore in Q3 FY25.
Declared an interim dividend of ₹2 per equity share with a record date of February 10, 2026.
Nine-month PAT for FY26 reached ₹543.83 crore, up from ₹483.01 crore in the previous year.
Board approved reclassification of Algavista Greentech Private Limited from 'Promoter' to 'Public' category.
💼 Action for Investors
Investors should note the steady double-digit growth in both revenue and profit, which supports the interim dividend payout. The stock remains a watch for long-term holders given its consistent operational performance and Murugappa Group backing.
Time Technoplast Subsidiary Partners with Monbat AD for ₹4,000 Cr Battery Opportunity
Time Technoplast's subsidiary, PowerBuild Batteries, has entered into an exclusive distribution and collaboration agreement with European battery manufacturer Monbat AD. This partnership focuses on supplying advanced VRLA battery solutions to India's rapidly growing data centre and BFSI sectors. The company identifies a total market opportunity of approximately ₹3,500-4,000 crore over the next decade, driven by massive digital infrastructure investments. This move aligns with the 'Make in India' initiative and leverages Monbat's global technology with PowerBuild's domestic service network.
Key Highlights
Exclusive distribution rights for Monbat's advanced VRLA stationary and reserve power batteries in India.
Targets a projected market opportunity of ₹3,500-4,000 crore over the next 10 years.
Capitalizes on India's data centre capacity growth, expected to add 3.0-3.5 GW over the next decade.
Supported by an estimated ₹2.3-2.5 lakh crore investment in the Indian data centre sector.
PowerBuild to provide pan-India technical support, installation, and after-sales services.
💼 Action for Investors
Investors should monitor the company's ability to secure contracts within the hyperscale data centre segment as this partnership opens a high-growth revenue stream. The stock may see positive sentiment due to the large addressable market and strategic alignment with India's digital infrastructure boom.
Satin Creditcare Q3 FY26 PAT Surges 404% YoY to INR 72 Cr; Consolidated AUM Hits INR 13,341 Cr
Satin Creditcare Network Limited reported a robust Q3 FY26 performance, with consolidated PAT jumping 404% YoY to INR 72 crore, marking its 18th consecutive profitable quarter. Consolidated AUM grew 10% YoY to INR 13,341 crore, supported by a 7% increase in disbursements during the first nine months of the fiscal year. Asset quality remained stable with standalone PAR 90 at 3.3%, while the company maintained a strong capital adequacy ratio of 24.64%. Management also highlighted strategic diversification, including a 51% stake acquisition in cybersecurity firm QTrino Labs.
Key Highlights
Consolidated PAT increased by 404% YoY to INR 72 crore for Q3 FY26.
Consolidated AUM reached INR 13,341 crore, representing a 10% YoY growth.
Standalone Net Interest Margin (NIM) remained healthy at 14.71% with PAR 90 at 3.3%.
Subsidiaries showed strong momentum: Satin Housing Finance AUM grew 26.3% and Satin Finserv grew 58.4% YoY.
Maintained high balance sheet liquidity of INR 2,283 crore and undrawn sanctions of INR 2,206 crore.
💼 Action for Investors
Investors should monitor the company's ability to maintain its low credit costs and stable NIMs amidst industry-wide headwinds. The strong growth in housing and MSME subsidiaries provides a diversified cushion, making the stock a positive prospect for long-term rural finance exposure.
Aarti Drugs Q3 FY26: PAT Jumps 58% YoY to ₹40.5 Cr; EBITDA Margins Contract to 9.3%
Aarti Drugs reported a mixed Q3 FY26 with revenue growing 8% YoY to ₹602.9 crore, led by strong growth in Formulations (+59%) and Specialty Chemicals (+51%). While PAT surged 58% YoY to ₹40.5 crore, operational EBITDA declined 10% YoY to ₹56.3 crore due to commissioning costs of new facilities and transient market dynamics. The company is aggressively pursuing backward integration, with its new Sayakha plant achieving 30% utilization and aiming for 100% self-reliance in Metformin intermediates within 8 months. Management indicates that pricing has reached an inflection point with improved momentum seen in January 2026.
Key Highlights
Consolidated Revenue grew 8% YoY to ₹602.9 crore, though API segment revenue slightly declined by 1% YoY.
EBITDA margins contracted by 190 bps YoY to 9.3% due to initial absorption of commissioning costs.
Formulations segment revenue rose 59% YoY to ₹76.4 crore, with exports accounting for 67% of this segment.
Sayakha plant for methyl amines achieved 30% capacity utilization in its first quarter of operations.
9M FY26 PAT stands at ₹139.7 crore, reflecting a 49% YoY growth compared to the previous year.
💼 Action for Investors
Investors should monitor the capacity ramp-up at the Sayakha and Tarapur facilities, as successful backward integration is key to margin recovery. While the YoY PAT growth is strong, the QoQ decline in EBITDA suggests operational pressures that need to stabilize in the coming quarters.
Aarti Drugs Q3 FY26: Revenue Up 8% to ₹603 Cr, PAT Surges 58% Aided by Tax Refund
Aarti Drugs reported a steady 8% YoY revenue growth to ₹602.9 crore for Q3 FY26, driven by domestic demand and export formulations. While PAT surged 58% to ₹40.5 crore, this was significantly bolstered by a ₹16.38 crore income tax refund. Operational performance faced pressure as EBITDA fell 10% YoY to ₹56.3 crore, with margins contracting to 9.3% due to high-cost inventory consumption and temporary maintenance shutdowns. The company is making strategic progress in backward integration, with its new Sayakha facility reaching 30% capacity utilization in its first quarter.
Key Highlights
Consolidated revenue grew 8% YoY to ₹602.9 crore, while 9M FY26 revenue reached ₹1,846.6 crore.
EBITDA margins contracted by 190 bps YoY to 9.3% due to inventory-related factors and scheduled maintenance.
PAT increased 58% YoY to ₹40.5 crore, inclusive of a one-time IT tax refund of ₹16.38 crore.
Sayakha backward integration plant achieved 30% capacity utilization; expected to reach 50% by April 2026.
API segment continues to dominate the revenue mix at 75.5%, followed by Formulations at 12.7%.
💼 Action for Investors
Investors should monitor the ramp-up of the Sayakha and Tarapur facilities, as successful backward integration is critical for margin recovery. While the PAT growth looks high, it is heavily influenced by a tax refund, so focus should remain on core EBITDA improvements in upcoming quarters.
Adroit Infotech Q3 Net Profit Jumps 180% YoY to ₹1.52 Cr; Board to Recover Unpaid Rights Money
Adroit Infotech Limited reported a robust performance for Q3 FY26, with consolidated revenue rising 86.5% YoY to ₹14.33 crore. Net profit for the quarter surged to ₹1.52 crore, up from ₹0.54 crore in the corresponding quarter of the previous year. The company's nine-month profit also showed strong growth, reaching ₹3.13 crore compared to ₹1.47 crore. Additionally, the board has approved issuing call notices to recover unpaid money on over 30.91 lakh shares from its previous rights issue.
Key Highlights
Consolidated revenue from operations grew to ₹1,432.67 Lakhs in Q3 FY26 from ₹768.11 Lakhs YoY.
Net profit after tax increased by 180.8% YoY to ₹152.41 Lakhs.
Nine-month consolidated profit stood at ₹313.45 Lakhs, a 112.7% increase over the previous year.
Board to issue call notices for unpaid 1st and 2nd call money on 30,91,222 equity shares.
Consolidated EPS for the quarter improved to ₹0.28 from ₹0.18 YoY.
💼 Action for Investors
The strong earnings growth and proactive steps to recover unpaid capital are positive signals for shareholders. Investors should monitor the successful collection of the rights issue money as it will strengthen the company's balance sheet.
Adroit Infotech Q3 FY26 PAT Jumps 181% YoY to ₹1.52 Cr; Board to Recover Unpaid Rights Issue Money
Adroit Infotech reported a strong performance for Q3 FY26, with consolidated revenue growing 86.5% YoY to ₹14.33 crore. Net profit for the quarter surged to ₹1.52 crore compared to ₹0.54 crore in the same period last year. The company is also taking active steps to recover unpaid call money from its previous rights issue, affecting approximately 30.91 lakh shares. For the nine-month period ended December 2025, the company has already surpassed its previous full-year profit figures.
Key Highlights
Consolidated revenue from operations increased 86.5% YoY to ₹1,432.67 Lakhs in Q3 FY26.
Net Profit (PAT) surged 181% YoY to ₹152.41 Lakhs from ₹54.28 Lakhs in the year-ago quarter.
9M FY26 PAT reached ₹313.45 Lakhs, more than doubling from ₹147.38 Lakhs in 9M FY25.
Board approved issuing call notices for unpaid money on 3,091,222 shares from the previous Rights Issue.
Basic EPS for the quarter improved to ₹0.28 compared to ₹0.18 in Q3 FY25.
💼 Action for Investors
The company is showing strong growth momentum in its core SAP support services. Investors should monitor the successful collection of unpaid rights issue money and the resulting impact on the equity base.
Aarti Drugs Q3 Net Profit Rises 9.3% YoY to ₹40.55 Cr; Declares ₹2 Interim Dividend
Aarti Drugs reported a consolidated net profit of ₹40.55 crore for Q3 FY26, marking a 9.3% growth compared to ₹37.09 crore in the same period last year. Revenue from operations increased 8.1% YoY to ₹601.71 crore, although it saw a sequential decline from ₹652.79 crore in Q2. The company declared an interim dividend of ₹2 per share (20%) with a record date of February 9, 2026. Additionally, the company strengthened its leadership by inducting three functional heads into the Senior Management Personnel category to align with organizational growth.
Key Highlights
Consolidated Net Profit for Q3 FY26 stood at ₹40.55 crore, up from ₹37.09 crore YoY.
Revenue from operations grew 8.1% YoY to ₹601.71 crore for the quarter ended December 31, 2025.
Declared an interim dividend of ₹2 per equity share with a record date fixed for February 9, 2026.
9M FY26 consolidated net profit reached ₹140.54 crore on a total revenue of ₹1,845.01 crore.
New manufacturing plant at Sayakha, Gujarat, which commenced operations in Sept 2025, is now contributing to production.
💼 Action for Investors
Investors may view the YoY growth and dividend declaration positively, though the sequential dip in revenue suggests monitoring margin pressures. Focus on the scaling of the new Sayakha plant as a primary growth catalyst for the upcoming quarters.
Adroit Infotech Q3 Net Profit Jumps 180% YoY to ₹1.52 Cr; Board to Recover Unpaid Rights Money
Adroit Infotech reported a robust consolidated net profit of ₹1.52 crore for Q3 FY26, a significant 180% increase from ₹0.54 crore in the previous year's corresponding quarter. Consolidated revenue from operations rose 86% YoY to ₹14.33 crore, indicating strong demand for its SAP support services. Additionally, the board has decided to issue call notices to recover unpaid money on over 30.91 lakh shares from its rights issue. This move is expected to bring in the remaining capital and finalize the rights issue process.
Key Highlights
Consolidated Revenue from Operations surged 86.5% YoY to ₹1,432.67 Lakhs in Q3 FY26.
Consolidated Net Profit rose to ₹152.41 Lakhs from ₹54.28 Lakhs in Q3 FY25.
9M FY26 Consolidated Net Profit reached ₹313.45 Lakhs compared to ₹147.38 Lakhs YoY.
Board to issue call notices for unpaid 1st and 2nd call money on 30,91,222 equity shares.
Consolidated EPS for the quarter increased to ₹0.28 from ₹0.18 YoY.
💼 Action for Investors
The company shows strong operational growth and is taking proactive steps to clean up its capital structure. Investors should view the earnings growth positively while watching for the completion of the rights issue fund collection.
Aarti Drugs Declares Rs 2 Interim Dividend; Sets February 9 as Record Date
Aarti Drugs Limited has announced an interim dividend of Rs 2 per equity share for the financial year 2025-26, representing a 20% payout on the face value of Rs 10. The Board of Directors approved this distribution during their meeting on February 3, 2026. The company has officially designated February 9, 2026, as the record date to identify shareholders eligible for the payment. This move reflects the company's commitment to sharing profits with its investors.
Key Highlights
Interim dividend of Rs 2 per equity share declared for FY 2025-26
Dividend payout represents 20% of the face value of Rs 10 per share
Record date for dividend eligibility fixed as February 9, 2026
Board meeting for the declaration was held on February 3, 2026
💼 Action for Investors
Investors seeking to receive the dividend should ensure they hold the shares before the ex-dividend date, typically one business day prior to the record date. Long-term investors may view this consistent payout as a sign of stable cash flow.
Motilal Oswal Q3FY26 Operating PAT Up 16% YoY to ₹611 Cr; Interim Dividend of ₹6 Declared
Motilal Oswal Financial Services reported a 16% YoY increase in operating PAT to ₹611 crores for Q3FY26, driven by a 32% growth in Asset and Private Wealth businesses. These annuity-style segments now contribute over 50% of the group's operating profit, with annual recurring revenue (ARR) reaching 65% of total net revenue. The company's Asset Management AUM grew 33% YoY to ₹1.89 lakh crores, while Private Wealth AUM rose 31% to ₹1.95 lakh crores. Reflecting strong performance, the board declared an interim dividend of ₹6 per share, a 20% increase from the previous year.
Key Highlights
Operating PAT grew 16% YoY to ₹611 crores; adjusted for new labor code impact, growth was 18%
Asset Management AUM reached ₹1.89 lakh crores (up 33% YoY) with a record 2.7% market share in Mutual Funds
Private Wealth Management AUM grew 31% YoY to ₹1.95 lakh crores, serving 8,200+ families
Housing Finance AUM increased 24% YoY to ₹5,379 crores with stable asset quality (GNPA at 1.4%)
Quarterly SIP flows crossed ₹4,500 crores, a 1.5x increase YoY, resulting in a 5% SIP market share
💼 Action for Investors
Investors should favor the stock for its structural shift toward high-margin annuity businesses and strong AUM growth. The increasing share of recurring revenue and market share gains in the AMC segment provide a high degree of earnings visibility.
Aarti Drugs Declares ₹2 Interim Dividend; Q3 Net Profit Rises 9.4% YoY to ₹40.54 Cr
Aarti Drugs has declared an interim dividend of ₹2 per share for FY 2025-26, setting February 9, 2026, as the record date. The company reported a consolidated net profit of ₹40.54 crore for Q3 FY26, representing a 9.4% growth year-on-year, though it saw a sequential decline from ₹45.16 crore in Q2. Revenue for the quarter stood at ₹601.71 crore, up 8.1% from the previous year's corresponding quarter. Additionally, the company highlighted the commencement of its new manufacturing plant in Sayakha, Gujarat, which began operations in September 2025.
Key Highlights
Declared interim dividend of ₹2 per equity share (20% of face value) with a record date of February 9, 2026.
Consolidated Q3 FY26 revenue reached ₹601.71 crore, an 8.1% increase over Q3 FY25.
Net profit for the quarter grew 9.4% YoY to ₹40.54 crore, while EPS stood at ₹4.44.
New manufacturing plant at Sayakha, Gujarat, successfully commenced commercial operations on September 4, 2025.
Strengthened leadership by appointing three new functional heads to the Senior Management Personnel team.
💼 Action for Investors
Investors should track the record date of February 9 to be eligible for the dividend and monitor the performance of the new Sayakha plant for its impact on future margins. While YoY growth is steady, the sequential decline in revenue and profit suggests a need to watch for cost pressures in the pharmaceutical segment.
Aarti Drugs Q3 Net Profit Rises 9.4% YoY to ₹40.5 Cr; Declares ₹2 Interim Dividend
Aarti Drugs reported a consolidated revenue of ₹601.7 crore for Q3 FY26, marking an 8.1% growth compared to ₹556.6 crore in the same period last year. Net profit for the quarter increased to ₹40.5 crore from ₹37.1 crore YoY, although it saw a sequential decline from ₹45.2 crore in Q2 FY26. The company declared an interim dividend of ₹2 per share (20%) with a record date of February 9, 2026. Performance was supported by the commencement of the new Sayakha, Gujarat plant earlier in the fiscal year.
Key Highlights
Consolidated Revenue from operations stood at ₹601.7 crore, up 8.1% YoY but down 7.8% QoQ.
Net Profit for the quarter reached ₹40.5 crore, a 9.4% increase over the previous year's ₹37.1 crore.
Interim dividend of ₹2 per equity share declared with a total payout of approximately ₹18.25 crore.
New manufacturing facility at Sayakha, Gujarat, which started in September 2025, is now contributing to operations.
Three functional heads in Marketing, Export Marketing, and Purchase elevated to Senior Management Personnel.
💼 Action for Investors
Investors may find the YoY growth and dividend declaration encouraging, though the sequential dip in profitability suggests monitoring margin pressures. Focus should remain on the volume ramp-up from the new Sayakha plant in the upcoming quarters.
Pidilite Q3 FY26: Consolidated PAT up 12% to ₹624 Cr with 9.3% Volume Growth
Pidilite Industries reported a steady Q3 FY26 performance with consolidated revenue growing 10.2% YoY to ₹3,699 Cr. Growth was primarily driven by a robust 9.3% underlying volume growth (UVG), with the core Consumer & Bazaar segment growing at 9.7%. Despite a one-time ₹53 Cr impact from new labor code provisions which spiked staff costs by 21%, EBITDA margins improved to 24.2%. Standalone PAT grew by 12.5% to ₹601 Cr, supported by gross margin expansion to 55.7% due to lower input costs.
Key Highlights
Consolidated Revenue grew 10.2% YoY to ₹3,699 Cr with an underlying volume growth of 9.3%
Gross Margins expanded to 55.7% from 53.7% YoY, benefiting from benign input prices
Consolidated PAT increased by 12.0% to ₹624 Cr, while Standalone PAT rose 12.5% to ₹601 Cr
Staff costs increased by 21.6% due to a one-time ₹53 Cr provision for the new labor code
Domestic B2B segment recorded strong growth with 15.6% UVG, though exports declined by 28.8%
💼 Action for Investors
Investors should focus on the strong volume growth and margin expansion which indicate high pricing power and operational efficiency. The one-time labor cost provision is non-recurring, suggesting even stronger underlying profitability for future quarters.
Pidilite Q3 FY26: Net Profit Up 12% to ₹624 Cr; Strong 9.3% Volume Growth
Pidilite Industries reported a strong performance for Q3 FY26, with consolidated net profit rising 12% YoY to ₹624 crore. Revenue grew by 10.2% to ₹3,699 crore, supported by a healthy 9.3% underlying volume growth (UVG) in the standalone business. The Consumer & Bazaar segment was the primary driver with 12.4% revenue growth, while gross margins expanded by over 200 bps due to lower input costs. Management remains optimistic about future demand, citing infrastructure push and favorable monsoons as key tailwinds.
Key Highlights
Consolidated Net Sales grew 10.2% YoY to ₹3,699 crore for the quarter ended December 2025.
Standalone Underlying Volume Growth (UVG) remained robust at 9.3% for the quarter.
Consumer & Bazaar (C&B) segment revenue increased by 12.4% with EBIT margins expanding to 31.2%.
Consolidated Gross Margins improved by 222 bps YoY, driven by softening raw material prices.
Consolidated EBITDA grew by 12.0% to ₹894 crore, maintaining a healthy margin of 24.2%.
💼 Action for Investors
Investors should take note of the consistent double-digit growth and margin expansion despite export headwinds in the B2B segment. The company's strong volume growth and market leadership in adhesives make it a resilient pick for long-term portfolios.